During the past decade, Szpital Kliniczny im Karola Jonschera conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Szpital Kliniczny im Karola Jonschera" are "COVID-19" (1 trials), "Cystic Fibrosis" (1 trials), "Exocrine Pancreatic Insufficiency" (1 trials), "Exocrine Pancreatic Insufficiency: Cystic Fibrosis" (1 trials) and "Hypertension, Pulmonary" (1 trials). Many other conditions were trialed in "Szpital Kliniczny im Karola Jonschera" in a lesser frequency.

Most popular intervention types in "Szpital Kliniczny im Karola Jonschera" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "EUR-1008 25,000 Units" (1 trials), "Kreon 25,000 Units" (1 trials), "Kreon® 25,000" (1 trials), "Macitentan" (1 trials) and "Panzytrat® 25,000" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Kliniczny im Karola Jonschera" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Kliniczny im Karola Jonschera". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Szpital Kliniczny im Karola Jonschera, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Kliniczny im Karola Jonschera, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".